the aid library

Sort by:

Direction:

Download (163)

View PDF (195)

Transgender people and HIV

D. Adams; J. Byrne; M. Cabra; et al. World Health Organization (2015) C_WHO

Policy Brief

Download (98)

View PDF (647)

The expanding epidemic of HIV-1 in the Russian Federation

C. Beyrer; A. L. Wirtz; G. O’Hara; et al. PLOS Medicine (2017) CC

PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002462 November 28, 2017

Download (96)

View PDF (904)

HIV Due to Female Sex Work: Regional and Global Estimates

A. Prüss-Ustün; J. Wolf; T. Driscoll; et al. Plos One (2013) CC

PLOS ONE | www.plosone.org May 2013 | Volume 8 | Issue 5 | e63476

Download (116)

View PDF (760)

Clinical and public health implications of acute and early HIV detection and treatment: a scoping review

Rutstein, S.E., J. Ananworanich, S. Fidler, et al. Journal of the International AIDS Society (2017) CC

Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579

Download (160)

View PDF (181)

The Global HIV Epidemics among Sex Workers

D. Kerrigan; A. Wirtz; I. Semini; et al. The World Bank (2013) C2

Directions in Development Human Development

Download (150)

View PDF (194)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (130)

View PDF (755)

Progress towards the UNAIDS 90–90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey

H. Huerga; G. van Cutsem; J. B. Farhat; et al. MBC Public Health; BioMed Central (2018) CC

BMC Public Health, Volume 18, Article number: 303 (2018) https://doi.org/10.1186/s12889-018-5208-0 Published: 02 March 2018

Download (114)

View PDF (131)

90-90-90, Epidemic Control and Ending AIDS: Global Situation and Recommendations

R. Granich; S. Gupta; B. Williams ClinMed International Library (2018) CC

Review Article Granich et al. Int J Virol AIDS 2018, 5:043 DOI: 10.23937/2469-567X/1510043 Volume 5 | Issue 1

Download (111)

View PDF (431)

Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review

Medina-Rincón, G.; Gallo-Bernal, S.; Jiménez, P.; et al. (2021) CC

Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493 .Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech... more

Download (37)

View PDF (65)

Desktop Helper No.2 - A practical guide to improve difficult-to-manage asthma in primary care

International Primary Care Respiratory Group IPCRG (2024) CC

This guide provides a systematic, practical approach to support primary care and other healthcare professionals to improve the care of peopel over the age of 18 years with difficult to manage asthma.

Download (119)

View PDF (159)

A four-step process for building sustainable access to diagnosis and treatment of Chagas disease

Batista, C.; Forsyth, C.; Herazo, F.; et al. Pan American Journal of Public Health (2019) CC

Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease (CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants, and via consumption of food or drink contaminated by triatomi... more

Download (111)

View PDF (305)

The multidimensional comprehension of Chagas disease

Sanmatino, M.; Forsyth, C.; Avaria, A. et al. (2022) C2

Chagas is a complex, multidimensional phenomenon in which political, economic, environmental, biomedical, epidemiological, psychological, and sociocultural factors intersect. Nonetheless, the hegemonic conceptualisation has long envisioned Chagas as primarily a biomedical question, while ignoring or... more

Download (126)

View PDF (165)

Ending Aids - Progress towards the 90-90-90 targets - Global Aids Update 2017

UNAIDS UNAIDS (2017) C2

Global AIDS Update 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS)

Download (393)

View PDF (2432)

Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen < 15 Jahren in Deutschland

Nicole Ritz, Folke Brinkmann, Cornelia Feiterna-Sperling. et al. Springer (2015) C2

Stellungnahme der Arbeitsgruppe AWMFLeitlinie Tuberkulose im Kindes- und Jugendalter: Diagnostik, Prävention und Therapie unter Federführung der Deutschen Gesellschaft für Pädiatrische Infektiologie. Monatsschr Kinderheilkd 2015 · 163:1287–1292 DOI 10.1007/s00112-015-0007-5 © Deutsche Gesel... more

Download (280)

View PDF (1309)

Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection

Staples JE, Dziuban EJ, Fischer M, et al (2016) C2

A printable copy of the article published in Morbidity and Mortality Weekly Report (MMWR) can be found on the CDC Homepage. Follow the Download Link for redirection to CDC.

Download (134)

View PDF (216)

Уровень знаний населения о факторах риска, принципах диагностики, лечения и профилактики острых нарушений мозгового кровообращения: анализ результатов опроса 2014 и 2017 годов

Щаницын И. Н., Раздорская В. В., Колоколов О. et al. Саратовский научно-медицинский журнал (2018) C1

Цель: оценка знаний населения об инсульте, а также определение степени влияния различных способов информирования граждан на уровень этих знаний. http://www.ssmj.ru/system/fil... more

Download (170)

View PDF (202)

Interventions for management of children with intellectual disabilities

World Health Organization (2012) C_WHO

Q3: What approaches are available to enable non-specialized health care providers to identify children with intellectual disabilities, including intellectual disabilities due to specific causes?

Download (155)

View PDF (172)

Special edition: HIV in MSM

I. Steffens; K. Hagmaier; K. Wilson; et al. Eurosurveillance (Europe’s journal on infectious disease epidemiology, prevention and control); European Centre for Disease Prevention and Control (2015) C2

Eurosurveillance Impact Factor 5.7 June 2015 www.eurosurveillance.org Featuring a series of articles on HIV and STI epidemiology, prevention and control among MSM in Europe

Download (122)

View PDF (1171)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature

Ocran Mattila, P.; R. Ahmad, S.Shahzad Hasan, et al. (2021) C2

Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744

Download (137)

View PDF (210)

A prospective “test-and-treat” demonstration project among people who inject drugs in Vietnam

H. H. Nguyen; D. D. Bui; T. T.T. Dinh; et al. Journal of the International AIDS Society; PubMed.gov (2018) CC

Nguyen HH et al. Journal of the International AIDS Society 2018, 21:e25151 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25151/full | https://doi.org/10.1002/jia2.25151